A recent
report published by Infinium Global Research on RNA therapy market provides an in-depth analysis of segments and sub-segments in the global as well as regional
RNA therapy market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional RNA therapy market
over the short term as well as long term. The report is a comprehensive
presentation of trends, forecast and dollar values of global RNA therapy
market. According to the report, the global RNA therapy market is projected to
grow at a CAGR of 8.5% over the forecast period of 2019-2025.
RNA therapy
is more accurate and targeted therapy because it targets particular protein, by
not harming other proteins in the cell. RNA based therapy is more customized
then many other drugs used in inherent and genetic disorders. The of RNA
therapeutics consists of several different kinds of technologies, including RNA
interference (RNAi) therapeutics, antisense therapies, nucleic acid or peptide
aptamers and microRNA therapeutics. RNA therapy to treat a wide variety of
diseases, including cardiovascular disease, hemophilia, and cancer. increased
number of viral disease globally is fueling the demand for RNA therapy.
Rising
genetic diseases, neurological disorders, and viral infections are the major
factors driving the RNA therapy market. Advancement in the sectors of molecular
technology, nanotechnology, and biology is likely to boost the RNA therapy
market. Completion of the human genome project has provided target sequences in
ample amount giving an opportunity for the development of RNA based
therapeutics. Moreover, rising biotechnology industries are contributing to the
growth of RNA therapy market. However, high cost associated with detection kits
and analytical instruments can hamper the growth of RNA therapy market. RNA
therapies are less toxic and provide a number of advantages over chemotherapy,
that can provide better opportunities for RNA therapy market.
Amongst the
geographical region, North America holds the largest market share in RNA
therapy market owing to conducting widespread research to commercialize the
therapeutics. Europe is second largest in the growth of RNA therapy market. The
emergence of various infectious diseases, genetic disease and neurological
diseases in this region contribute to the growth of RNA therapy market in these
regions. The Asia Pacific is one of the fastest growing market owing to
technological advances making it more effective and consumable hence, boosting
the growth of RNA therapy market.
The report on
global RNA therapy market covers segments such as technology, and application.
On the basis of technology, the sub-markets include enabling technologies,
enabled technologies, RNA antisense technologies, and RNA interference (RNAi)
technologies. On the basis of application, the sub-markets include kidney
diseases, cardiovascular, infectious diseases, oncology, metabolic disorders,
and other applications.
The report
provides profiles of the companies in the market such as Silence Therapeutics,
Cenix BioScience GmbH, Sanofi Genzyme, Benitec Biopharma Ltd, Arbutus Biopharma
Corporation, DiceRNA Pharmaceuticals, Alnylam Pharmaceuticals Inc., Quark
Pharmaceuticals, and Other Companies.
The report
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors
that are driving and restraining the growth in this market. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of RNA therapy market. Moreover, the study
highlights current market trends and provides forecast from 2019-2025. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.
Please Choose One of them.